Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well metformin hydrochloride works compared to
placebo in treating patients with prostate cancer undergoing surgery. Metformin hydrochloride
may make some enzymes active. These enzymes may block other enzymes needed for cell growth
and stop the growth of tumor cells.